Novel metabolic drugs and blood pressure: implications for the treatment of obese hypertensive patients?
about
Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessmentsSGLT2 inhibition: efficacy and safety in type 2 diabetes treatment.A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats.
P2860
Novel metabolic drugs and blood pressure: implications for the treatment of obese hypertensive patients?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel metabolic drugs and bloo ...... f obese hypertensive patients?
@en
type
label
Novel metabolic drugs and bloo ...... f obese hypertensive patients?
@en
prefLabel
Novel metabolic drugs and bloo ...... f obese hypertensive patients?
@en
P2860
P1476
Novel metabolic drugs and bloo ...... f obese hypertensive patients?
@en
P2093
Jens Jordan
Stefan Engeli
P2860
P2888
P304
P356
10.1007/S11906-013-0374-Z
P577
2013-10-01T00:00:00Z
P6179
1051299033